Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Pagliuca

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
American Journal of Hematology|February 5, 2025
Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative StudyAnne Beatrice Notarantonio, Stéphane Morisset, Romain Piucco, et al.
American Journal of Hematology|July 24, 2023
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trialAnne Béatrice Notarantonio, Maud D'aveni-Piney, Simona Pagliuca, et al.
Blood|November 8, 2021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disordersSimona Pagliuca, Carmelo Gurnari, Hassan Awada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Régis Peffault de Latour, Fernanda Volt, et al.
Bone Marrow Transplantation|June 2, 2026
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeEsteban Arrieta-Bolaños, Alberto Cardoso Martins Lima, Marco Andreani, et al.
Blood Advances|March 4, 2026
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMTNicole Santoro, Jarl Eduard Mooyaart, Urban Novak, et al.
Nature Communications|May 30, 2023
Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
American Journal of Hematology|February 5, 2025
Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative StudyAnne Beatrice Notarantonio, Stéphane Morisset, Romain Piucco, et al.
American Journal of Hematology|July 24, 2023
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trialAnne Béatrice Notarantonio, Maud D'aveni-Piney, Simona Pagliuca, et al.
Blood|November 8, 2021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disordersSimona Pagliuca, Carmelo Gurnari, Hassan Awada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Régis Peffault de Latour, Fernanda Volt, et al.
Bone Marrow Transplantation|June 2, 2026
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeEsteban Arrieta-Bolaños, Alberto Cardoso Martins Lima, Marco Andreani, et al.
Blood Advances|March 4, 2026
OUTCOMES OF PATIENTS OVER 70 YEARS TREATED WITH BREXU-CEL FOR R/R MANTLE CELL LYMPHOMA: A STUDY FROM THE CTIWP OF EBMTNicole Santoro, Jarl Eduard Mooyaart, Urban Novak, et al.
Nature Communications|May 30, 2023
Molecular patterns identify distinct subclasses of myeloid neoplasiaTariq Kewan, Arda Durmaz, Waled Bahaj, et al.
Pageof 10